4//SEC Filing
OSBORNE DAVID W 4
Accession 0001567619-22-008817
CIK 0001787306other
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 6:32 PM ET
Size
5.3 KB
Accession
0001567619-22-008817
Insider Transaction Report
Form 4
OSBORNE DAVID W
Chief Technical Officer
Transactions
- Sale
Common Stock
2022-04-21$20.42/sh−2,197$44,872→ 257,229 total
Footnotes (3)
- [F1]Transaction made pursuant to a 10b5-1 trading plan adopted by the Reporting Person.
- [F2]The transaction was executed in multiple trades in prices ranging from $20.125 to $20.925, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide to the Securities and Exchange Commission staff, the Issuer, or a security holder of the Issuer, upon request, full information regarding the number of shares sold at each respective price within the range set forth in this footnote.
- [F3]Includes 24,925 RSUs.
Documents
Issuer
Arcutis Biotherapeutics, Inc.
CIK 0001787306
Entity typeother
Related Parties
1- filerCIK 0001252999
Filing Metadata
- Form type
- 4
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 6:32 PM ET
- Size
- 5.3 KB